SEATTLE GENETICS INC's ticker is SGENXXXX and the CUSIP is 812578102. A total of 301 filers reported holding SEATTLE GENETICS INC in Q2 2017. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $1,595,000 | +52.0% | 9,384 | +3.2% | 1.34% | +20.3% |
| Q1 2020 | $1,049,000 | -2.4% | 9,090 | -3.4% | 1.12% | +13.6% |
| Q4 2019 | $1,075,000 | +8858.3% | 9,409 | +4276.3% | 0.98% | +6037.5% |
| Q4 2018 | $12,000 | -29.4% | 215 | 0.0% | 0.02% | 0.0% |
| Q3 2018 | $17,000 | -99.0% | 215 | -99.3% | 0.02% | -98.1% |
| Q2 2017 | $1,622,000 | -14.4% | 31,341 | +4.0% | 0.83% | -20.8% |
| Q1 2017 | $1,895,000 | +11.2% | 30,149 | -6.6% | 1.04% | +9.0% |
| Q4 2016 | $1,704,000 | -15.1% | 32,284 | -13.1% | 0.96% | +33.8% |
| Q3 2016 | $2,007,000 | +69.8% | 37,160 | +21.3% | 0.72% | +94.8% |
| Q3 2015 | $1,182,000 | -13.7% | 30,646 | +8.3% | 0.37% | -39.3% |
| Q2 2015 | $1,370,000 | – | 28,305 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 45,725,556 | $2,487,928,000 | 20.18% |
| Lagoda Investment Management, L.P. | 306,694 | $16,687,000 | 6.03% |
| NEXTHERA CAPITAL LP | 373,000 | $20,295,000 | 5.22% |
| Redmile Group, LLC | 1,843,733 | $100,318,000 | 4.95% |
| Matrix Capital Management Company, LP | 2,118,000 | $115,240,000 | 3.68% |
| Sio Capital Management, LLC | 100,000 | $5,441,000 | 2.82% |
| Opus Point Partners Management, LLC | 41,263 | $2,245,000 | 2.01% |
| Eventide Asset Management | 525,000 | $28,565,000 | 1.62% |
| EMORY UNIVERSITY | 35,982 | $1,958,000 | 1.55% |
| Everett Capital Advisors UK LLP | 191,500 | $10,420,000 | 1.54% |